AxoGen EPS - Earnings per Share 2011-2025 | AXGN
AxoGen eps - earnings per share from 2011 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| AxoGen Annual EPS | |
|---|---|
| 2024 | $-0.23 |
| 2023 | $-0.51 |
| 2022 | $-0.69 |
| 2021 | $-0.65 |
| 2020 | $-0.60 |
| 2019 | $-0.74 |
| 2018 | $-0.60 |
| 2017 | $-0.31 |
| 2016 | $-0.47 |
| 2015 | $-0.51 |
| 2014 | $-0.99 |
| 2013 | $-1.08 |
| 2012 | $-0.85 |
| 2011 | $-2.77 |
| 2010 | $-8.35 |
| AxoGen Quarterly EPS | |
|---|---|
| 2025-09-30 | $0.01 |
| 2025-06-30 | $0.01 |
| 2025-03-31 | $-0.08 |
| 2024-12-31 | $0.00 |
| 2024-09-30 | $-0.04 |
| 2024-06-30 | $-0.04 |
| 2024-03-31 | $-0.15 |
| 2023-12-31 | $-0.08 |
| 2023-09-30 | $-0.10 |
| 2023-06-30 | $-0.16 |
| 2023-03-31 | $-0.17 |
| 2022-12-31 | $-0.14 |
| 2022-09-30 | $-0.10 |
| 2022-06-30 | $-0.18 |
| 2022-03-31 | $-0.27 |
| 2021-12-31 | $-0.13 |
| 2021-09-30 | $-0.17 |
| 2021-06-30 | $-0.19 |
| 2021-03-31 | $-0.16 |
| 2020-12-31 | $-0.15 |
| 2020-09-30 | $-0.04 |
| 2020-06-30 | $-0.20 |
| 2020-03-31 | $-0.21 |
| 2019-12-31 | $-0.18 |
| 2019-09-30 | $-0.14 |
| 2019-06-30 | $-0.18 |
| 2019-03-31 | $-0.24 |
| 2018-12-31 | $-0.13 |
| 2018-09-30 | $-0.11 |
| 2018-06-30 | $-0.20 |
| 2018-03-31 | $-0.16 |
| 2017-12-31 | $-0.08 |
| 2017-09-30 | $-0.06 |
| 2017-06-30 | $-0.06 |
| 2017-03-31 | $-0.11 |
| 2016-12-31 | $-0.18 |
| 2016-09-30 | $-0.08 |
| 2016-06-30 | $-0.09 |
| 2016-03-31 | $-0.12 |
| 2015-12-31 | $-0.11 |
| 2015-09-30 | $-0.11 |
| 2015-06-30 | $-0.13 |
| 2015-03-31 | $-0.16 |
| 2014-12-31 | $-0.35 |
| 2014-09-30 | $-0.19 |
| 2014-06-30 | $-0.21 |
| 2014-03-31 | $-0.24 |
| 2013-12-31 | $-0.21 |
| 2013-09-30 | $-0.25 |
| 2013-06-30 | $-0.31 |
| 2013-03-31 | $-0.31 |
| 2012-12-31 | $-0.37 |
| 2012-09-30 | $-0.20 |
| 2012-06-30 | $-0.09 |
| 2012-03-31 | $-0.19 |
| 2011-12-31 | $3.69 |
| 2011-09-30 | $-2.60 |
| 2011-06-30 | $-1.65 |
| 2011-03-31 | $-2.21 |
| 2010-12-31 | $-7.19 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.078B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $213.267B | 25.34 |
| Intuitive Surgical (ISRG) | United States | $196.642B | 76.93 |
| IDEXX Laboratories (IDXX) | United States | $57.510B | 57.11 |
| Edwards Lifesciences (EW) | United States | $48.635B | 32.23 |
| Alcon (ALC) | Switzerland | $36.668B | 24.62 |
| IQVIA Holdings (IQV) | United States | $35.783B | 19.95 |
| Mettler-Toledo (MTD) | United States | $29.657B | 35.20 |
| STERIS (STE) | Ireland | $23.951B | 24.64 |
| DexCom (DXCM) | United States | $23.120B | 31.87 |
| Waters (WAT) | United States | $22.145B | 29.29 |
| Hologic (HOLX) | United States | $16.510B | 17.38 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.063B | 0.00 |
| Penumbra (PEN) | United States | $8.796B | 62.13 |
| Globus Medical (GMED) | United States | $8.307B | 19.16 |
| Masimo (MASI) | United States | $7.635B | 24.47 |
| Sysmex ADR (SSMXY) | Japan | $6.484B | 20.60 |
| Teleflex (TFX) | United States | $5.513B | 8.90 |
| Glaukos (GKOS) | United States | $4.845B | 0.00 |
| TransMedics (TMDX) | United States | $4.253B | 50.39 |
| Veracyte (VCYT) | United States | $3.622B | 41.48 |
| Alphatec Holdings (ATEC) | United States | $2.929B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.774B | 14.99 |
| Integer Holdings (ITGR) | United States | $2.388B | 11.21 |
| Artivion (AORT) | United States | $2.195B | 110.74 |
| Nihon Kohden (NHNKY) | Japan | $1.980B | 23.63 |
| PROCEPT BioRobotics (PRCT) | United States | $1.759B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.736B | 16.82 |
| Beta Bionics (BBNX) | United States | $1.167B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.095B | 0.00 |
| IRadimed (IRMD) | United States | $1.081B | 51.49 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.991B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.888B | 4.81 |
| SiBone (SIBN) | United States | $0.663B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.591B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.575B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.541B | 31.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.495B | 9.87 |
| AngioDynamics (ANGO) | United States | $0.491B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.483B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.435B | 3.42 |
| NeuroPace (NPCE) | United States | $0.432B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.411B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.408B | 10.38 |
| Treace Medical Concepts (TMCI) | United States | $0.395B | 0.00 |
| RxSight (RXST) | United States | $0.341B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.336B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.307B | 51.06 |
| Spectral Diagnostics (EDTXF) | Canada | $0.292B | 0.00 |
| 908 Devices (MASS) | United States | $0.290B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.263B | 0.00 |
| CVRx (CVRX) | United States | $0.256B | 0.00 |
| Inogen (INGN) | United States | $0.200B | 0.00 |
| Neuronetics (STIM) | United States | $0.188B | 0.00 |
| Accuray (ARAY) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.145B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.142B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Hyperfine (HYPR) | United States | $0.089B | 0.00 |
| InspireMD (NSPR) | United States | $0.088B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.080B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.079B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.061B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.66 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |